Carlyle Group and CG Oncology’s Cancer Breakthrough Sparks Investor Interest
Carlyle Group Inc. and its associated biotech company CG Oncology have seen a surge in investor interest following CG Oncology’s announcement of promising results for a new bladder cancer treatment.
2 minutes to read